This InspectorProfile is a report of relevant audit-related information on Samina Khan, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Samina Khan's 67 inspections in 14 countries: United States, France, United Kingdom, Japan, China, Switzerland, Germany, Canada, India, Italy, Korea (the Republic of), Ireland, Taiwan, and Denmark.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Samina Khan's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Samina Khan.
Note: The EIR and 483 documents are sold separately.Add To Cart10 of Samina's 483s Available Now.